ReferenceRRK6436

NUC-5

Double-blind randomized placebo-controlled phase III study comparing norursodeoxycholic acid capsules with placebo in the treatment of primary sclerosing cholangitis

Research Summary

Research Overview
Sponsor Dr. Falk Pharma GmbH
Project Status Open
Proposed End Date 31/08/2023
Study Run through CRF? No
Target number of patients agreed to recruit 2
Recruitment so far 2